Evidence map›Paper›PMID 41853315›Full record

ArticleFrontiers in oncology2026

Multi-institutional MRI-based radiomic pilot study to measure the variations between scanner vendors and imaging sessions.

Suong Duong, Danny Lee, Carri Glide-Hurst, Bhudatt Paliwal, Jennie Crosby, Michael Boss, Yunfeng Cui, Mi Huang, Heng Li, Khadija Sheikh and 5 more

Abstract read
In one paragraph

Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Suong DuongDepartment of Environmental Protection, Pennsylvania Commonwealth, Pittsburgh, PA, United States.
Danny LeeDepartment of Radiation Oncology, Allegheny Health Network, Pittsburgh, PA, United States.
Carri Glide-HurstDepartment of Human Oncology, University of Wisconsin-Madison, Madison, WI, United States.
Bhudatt PaliwalDepartment of Human Oncology, University of Wisconsin-Madison, Madison, WI, United States.
Jennie CrosbyDepartment of Human Oncology, University of Wisconsin-Madison, Madison, WI, United States.
Michael BossCenter for Research and Innovation, American College of Radiology, Philadelphia, PA, United States.
Yunfeng CuiRadiation Oncology, Duke University Hospital, Durham, NC, United States.
Mi HuangDepartment of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI, United States.
Heng LiDepartment of Radiation Oncology, Johns Hopkins University, Baltimore, MD, United States.
Khadija SheikhDepartment of Radiation Oncology, Johns Hopkins University, Baltimore, MD, United States.
Taeho KimDepartment of Radiation Oncology, Washington University in St Louis, St. Louis, MO, United States.
James MonroeDepartment of Radiation Oncology, St Louis VA Medical Center-Jefferson Barracks, St. Louis, MO, United States.
Jung Hun OhDepartment of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY, United States.
Ying XiaoDepartment of Radiation Oncology, University of Pennsylvania, Philadelphia, PA, United States.
Jason W SohnDepartment of Radiation Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

Background: Multi-institutional clinical trials frequently use MRI imaging for critical decisions and guidance for medical treatments. Collecting and analyzing images produced by various MR vendors and models is quite difficult since image quality can be highly variable. No unifying quality control targeting protocol studies exists to ensure MRI images used in that study are comparable. This project will investigate variations between imaging sessions and between various scanners using radiomic parameters from prototype MRI QA phantom. Purpose: To develop a 3D radiomic phantom for quantifying radiomic feature consistency between MRI scanners across multi-institutions. Methods: The prototype phantom consists of five 3D-printed objects (3 grid and 2 egg-shape) using Polylactic Acid (PLA) with/without 20% wood particles placed in a water container. The grid objects consisted of PLA scaffolding with 245 cubic voids (flood-filled by water) stacked in 7rows x 7columns x 5layers with volumes of 3x3x3 mm Results: The radiomic feature consistency varied across objects with less reproducibility for the egg-shaped objects and more reproducibility for the grid objects, with slightly better reproducibility for T1w than T2w sequences. The GE scanner demonstrated better reproducibility than the other scanners. Both ViewRay scanners showed consistency for acquisitions with the TrueFISP sequence; the median CV of 107 radiomic features between objects was <10%). The consistency was summarized in a heat map. Conclusion: Some radiomic features showed significant intra-scanner variations. This study demonstrated that a standardized radiomic phantom is required to characterize individual scanners and MR sequences for establishing the baseline of radiomic features, which could be important for multi-institutional radiomic studies using MRI.

Indexed as

3D printingMRImulti-institutionphantomradiomic features

Identifiers

PMID41853315
PMCPMC12992046

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.